Background: Poor medication adherence is associated with adverse health outcomes and higher costs of care. However, inconsistencies in the assessment of adherence are found in the literature. Objective: To evaluate the effect of different measures of adherence in the comparative effectiveness of complex interventions to enhance patients' adherence to prescribed medications. Methods: A systematic review with network meta-analysis was performed. Electronic searches for relevant pairwise meta-analysis including trials of interventions that aimed to improve medication adherence were performed in PubMed. Data extraction was conducted with eligible trials evaluating short-period adherence follow-up (until 3 months) using any measure of adherence: self-report, pill count, or MEMS (medication event monitoring system). To standardize the results obtained with these different measures, an overall composite measure and an objective composite measure were also calculated. Network meta-analyses for each measure of adherence were built. Rank order and surface under the cumulative ranking curve analyses (SUCRA) were performed. Results: Ninety-one trials were included in the network meta-analyses. The five network meta-analyses demonstrated robustness and reliability. Results obtained for all measures of adherence were similar across them and to both composite measures. For both composite measures, interventions comprising economic + technical components were the best option (90% of probability in SUCRA analysis) with statistical superiority against almost all other interventions and against standard care (odds ratio with 95% credibility interval ranging from 0.09 to 0.25 [0.02, 0.98]). Conclusion: The use of network meta-analysis was reliable to compare different measures of adherence of complex interventions in short-periods follow-up. Analyses with longer follow-up periods are needed to confirm these results. Different measures of adherence produced similar results. The use of composite measures revealed reliable alternatives to establish a broader and more detailed picture of adherence.
Introduction
The high rates of poor medication adherence are recognized as amajor worldwide health problem, being associated with adverse health outcomes and higher costs of care. However, there is a high variability, not only in the report of the prevalence and costs associated to nonadherence, 1,2 but also across studies assessing different types of interventions aiming to improve patient's medication adherence. 3 In addition to the consequences of ignoring the different components of the adherence process (i.e., initiation, implementation and discontinuation), 4 a potential cause for this inconsistency may be the methodological issue on the choice of measurements to assess medication adherence in randomized controlled trials. 5 Measurements of medication adherence are important estimates that can provide better evidence on the consequences, determinants, risk factors, and interventions to improve adherence. 6 There are numerous subjective and objective methods available for assessing medication adherence [7] [8] [9] being: patient self-reports (e. questionnaires), pill counts (e.g. comparing the number of doses remaining in a container with the number of doses that should remain), and electronic capture of pill bottle opening (Medication Event Monitoring Systems -MEMS) the most used in routine practice. 5 Previous studies assessing the concordance of all these measures have yielded conflicting results and, to date, no universally agreed consensus on the most ideal method to assess medication adherence exists. 10, 11 Another drawback for the selection of the most effective interventions to improve medication adherence is the low number of studies comparing them directly and simultaneously. Most of the clinical trials assessing interventions aiming at enhancing patient's medication adherence usually compare one or two interventions against a standard or usual care. 3 New comparative statistical methods, such as network meta-analyses, can provide a broader overview of the effect of all interventions in one single model, while reducing bias. 12 Also known as indirect meta-analysis or multiple treatment comparisons, this technique was developed as an extension of pairwise meta-analysis and combines both direct (i.e., based on existing comparative studies in the literature) with indirect evidence (i.e., based on common comparators when direct evidence is not available) to obtain pooled effects sizes. 13 However, limited research has been undertaken to statistically determine the comparative effect of non-pharmacological complex interventions to improve medication adherence. To date, few network metaanalysis on this topic have been published, being mostly focused on interventions targeted at patients with viral infections. [14] [15] [16] Thus, the objective of this study was to perform a systematic review with network meta-analysis to assess the impact of the different measures of adherence used to compare the effectiveness of complex interventions to enhance patients' adherence to prescribed medications in any medical condition.
Methods
This systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Network Meta-analyses (PRISMA NMA) 17 and Cochrane Collaboration recommendations. 18 The protocol is registered on PROSPERO (CRD42018054598).
Search strategy and eligibility criteria
The literature selection was performed in two steps. First, searches in the medical literature for relevant pairwise meta-analyses that compared complex interventions to improve medication adherence in adult patients with any clinical condition were performed. The searches were conducted in PubMed (in October 2017) without any restriction based on publication date or language. The complete search strategy used to identify the meta-analyses is available in supplementary material. Two independent reviewers performed the screening (by title and abstract reading) and full-text appraisal of the meta-analyses identified. Discrepancies were resolved with a third reviewer during consensus meetings.
In a second step, primary studies included in the meta-analyses identified in the first step were extracted. Two independent reviewers performed the screening and full-text appraisal of these primary studies with contributions from the third reviewer in case of disagreements. Finally, studies of interventional design (i.e. randomized or non-randomized trials) that compared any intervention aimed at improving patients' medication adherence versus another intervention or standard care were included. The outcome of interest was medication adherence. Studies evaluating short-period results (follow-up until 3 months) that reported adherence using any the following measures: self-reported measures (i.e. here named as self-report), calculated adherence rates from dispensing data, pill counts or estimates from a healthcare professional records (i.e. here named as pill count), and electronic monitoring of bottle or pill box opening (i.e. generic named as MEMS: medication event monitoring system) were included. Studies including pediatric population (under 18 years), other type of treatments (over-the-counter medications, depot medications, vaccines), articles not defining the adherence measure or not evaluating medication adherence, studies without a comparison group, and articles where the intervention was given to the health care provider rather than to the patient, were excluded. Unpublished studies, letters to editor, commentaries, books and articles written in non-Roman characters were also excluded.
Data extraction, variable definitions and quality assessment
Using a standard data sheet, data extraction was performed from articles that met the inclusion criteria: study baseline characteristics (authors' names, year of publication, country, sample size, patients' clinical conditions, sex and age, trial follow-up, evaluated interventions), (ii) methodological aspects (e.g. trial design) (iii) measures of adherence (i.e. self-report, pill count, MEMS); and the respective rates of adherent patients for each measure. The outcome of adherence was defined by the proportion of patients in each study arm meeting the trial defined adherence criteria (e.g. proportion of doses taken over a defined time) with various cutoff values (90%, 95%, 99%, 100%).
To better standardize the results obtained with the different adherence measures, two additional measures were calculated: an overall composite measure and an objective composite measure. The overall composite measure represents the rate of adherent patients obtained from any of the measures (self-report, pill count or MEMS) in each study. If more than one measure was reported in the study, a mean among the rates of adherent patients from the different measures was calculated. The objective composite measure considers only the results obtained from objective methods (pill count or MEMS), calculating the mean if both measures were reported in the study.
To improve interpretability, the adherence-enhancing interventions were grouped in the following categories: attitudinal, economic, educational, technical, as defined in Table 1 . These categories represent the single components of complex interventions and were created based on previous literature definitions. [19] [20] [21] [22] [23] Multicomponent interventions included more than one single category (e.g. attitudinal + economic). Standard care was considered as the usual care defined in the primary study (e.g., regular medication pick-ups including consultations with Table 1 Categories of interventions for improving medication adherence.
Component Definition
Attitudinal Interventions aiming to modify behavioral intention (theory of planned behavior) based on modifying patient's attitudes or subjective norm, delivered in any form (e.g. written, oral, in group, by telephone). Economic
Interventions that produce awards (or penalties) associated to a better (or worst) medication adherence. Educational Every intervention where a professional provided any type of knowledge (e.g. medication information, disease state information, importance of adherence information), in any form (e.g. written, oral, in group, by telephone), to a patient with the aim of modifying patient's beliefs, attitudes or skills that facilitate adherence.
Technical
Interventions providing any gadget, instrument, or system that facilitate the medication intake, through reminders, regime simplifications, follow-ups, direction observation therapy, self-monitoring, cue-dose training, feedback.
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physician or pharmacist). The methodological quality of the included studies was assessed by two independent reviewers using the Cochrane Collaboration Risk of Bias Assessment tool (RoB). 18 The criteria for judgment of some domains of the RoB tool were adapted to this study, giving the complexity of the interventions.
Data analysis
Network meta-analysis is a technique recommended by the International Society for Pharmacoeconomics and Outcome Research to compare the profile among different interventions. 13, 24 To inform the comparative adherence rates among the different measures for all the interventions, a network meta-analysis using Bayesian framework for each measure of adherence (i.e. self-report, pill count, MEMS, overall composite measure, objective composite measure) based on the Markov Chain Monte Carlo simulation method (burn-in of 20,000 iterations and 50,000 iterations for estimation) was performed. Arm-level entry data was used. For the inclusion of multiple-arms studies, correlations for in the likelihood between arms were considered. A common heterogeneity parameter was assumed for all comparisons. A conservative analysis of non-informative priors was used. 25, 26 Effect sizes measures were expressed as odds ratio (OR) with a 95% credibility interval (CrI). Both fixed and random-effect models were tested and the one with the lowest deviance information criteria (DIC) was selected. Convergence was attained based on visual inspection of Brooks-Gelman-Rubin plots and potential scale reduction factor -PSRF (1 < PSRF≤1.05). 26, 27 To increase the estimate precision of the relative effect sizes of comparisons and to properly account for correlations between multi-arm trials, ranking probabilities for each measure of adherence were calculated via surface under the cumulative ranking analysis (SUCRA). 28 SUCRA values can range from 0% (i.e. the intervention always ranks last) to 100% (it always ranks first). To estimate the robustness of the network, inconsistency, defined as the difference between the pooled direct and indirect evidence for a comparison, was assessed using node-splitting analysis (p-values < 0.05 reveal significant inconsistencies in the network). 29 All analyses were performed using software Addis version 1.17.6 (Aggregate Data Drug Information System; http://drugis.org/ addis). 30 To validate the composite measures, additional analyses were performed to evaluate the contribution of each single component of the complex interventions (i.e. attitudinal, economic, educational, technical) on patients' adherence. A score was created to rank single components in each adherence measure according to the results obtained in the rank order. The score was calculated as the mean of the ordinal positions of the interventions comprising each component (Score = Ʃ positions occupied by the component in the rank order/frequency of the component). For instance, a component included in interventions positioned as first, third and fifth, would score 3 [(1 + 3+5)/3].
Results
The systematic review process identified 920 records on medication adherence, of which 61 were meta-analyses and had their references (primary studies) extracted (see supplementary material for complete references). From the initial 1119 primary studies included in the 61 meta-analyses, 689 were fully assessed for eligibility, with 168 studies finally included in the qualitative synthesis (see supplemental material for complete references). Of these, 91 studies reported dichotomous results on patients' adherence and subsequently were included in the network meta-analyses (Fig. 1) .
The 168 included studies were published between 1971 and 2016, with a median in 2006 (IQR, 1999 (IQR, -2011 . Studies included 42,338 participants. Most of them had a follow-up period of 12 weeks (25.0%), followed by studies with 4-6 weeks (17.9%) and 8-10 weeks (17.9%). The evaluated interventions were: educational (n = 63 studies); technical (n = 56); attitudinal (n = 28); educational + attitudinal (n = 23); educational + technical (n = 23); educational + attitudinal + technical (n = 5); attitudinal + technical (n = 2); economic (n = 1); economic + technical (n = 1); attitudinal + technical + economic (n = 1). Standard care was the comparator in 151 studies (89.9%).
Overall, the included studies were classified as having unclear risk of bias according to the RoB tool. Only 10 studies (5.9%) were not randomized. Around 50% of the trials properly described the random sequence generation, but more than 75% were unclear about the allocation concealment. Eighty-one studies were blinded, being 53% singleblinded. For the domains of detection bias and reporting bias, more than 80% of studies were considered with low risk of bias. However, around 20% were classified as having high risk of bias for the attrition domain, because losses in the study were high and authors did not report the reasons for missing outcome data. Less than 10% of studies were funded by the industry or presented conflict of interest (supplementary material).
Five network meta-analyses, one for each adherence measure, were built. The network diagrams of the possible comparisons of interventions are presented in Fig. 2 The network of self-report measure (Fig. 2a) Table 2 and complete graphs in supplemental material), the multicomponent intervention educational + attitudinal + technical presented the higher probability of being the best alternative for enhancing patients' adherence (73% of probability), followed by educational + technical (67%). Standard care was considered the worst option (8%).
For the network of the pill count measure (Fig. 2b) , 30 studies were evaluated reporting data on the following interventions: economic + technical; educational + technical; educational + attitudinal; educational, and technical. The intervention economic + technical was statistically superior to all the other interventions and to standard care [OR 0.10 (0.03, 0.35)]. Educational + technical, educational, and technical were again superior to standard care. For complete consistency analyses, see the supplemental material. By SUCRA analysis (see Table 2 and complete graphs in supplemental material), the multicomponent economic + technical was ranked as the best alternative (99% of probability), followed by educational + technical (76%). Standard care was again the last option (12%).
The measure MEMS was assessed in 22 studies (Fig. 2c) . The interventions economic + technical and educational + technical were not evaluated for this measure. Statistical differences were observed between educational + attitudinal and standard care [OR 0.27 (0.13, 0.57)] and standard care and technical [OR 2.25 (1.33, 3.91)], both favoring the interventions (for complete consistency analyses see supplemental material). Attitudinal + technical and economic were considered the best interventions (77% and 75% of probability, respectively), while standard care was ranked last (7%) ( Table 2 ).
The two composite measures (overall composite measure and objective composite measure) presented similar results for the networks (Fig. 2d and e) , consistency analyses and rank orders, evaluating the same 10 interventions and standard care (n = 91 and n = 50 studies included, respectively). For both measures, the intervention economic + technical was the best option (around 90% of probability in the SUCRA analysis) ( Table 2 ) and presented statistical superiority (see Fig. 3 ) against almost all the other interventions and usual care (OR with 95% CrI varying from 0.09 (0.02, 0.33) to 0.25 (0.05, 0.98)). The multicomponent interventions educational + attitudinal, and educational + technical, and the single components educational and technical were statistically better than standard care for both measures. Standard care was ranked as the worst option with less than 6% of probability for both measures.
The additional analyses of the effect of the single components of complex interventions on patients' adherence using different measures is showed in Table 3 (see supplemental material for complete calculation of the score). Whenever reported, the economic component, always followed by the technical component, presented better results for the score, similarly to the results obtained in the networks of different measures. Educational or attitudinal components were ranked after, and standard care was always considered the worst option.
Discussion
This is the first systematic review with network meta-analysis to synthetize evidence on the impact of different measures of adherence used to assess the effectiveness of complex interventions to enhance patient's medication adherence during short periods of follow-up. Network meta-analysis are increasingly used statistical tools to provide information on the relative merits of interventions that have never been directly compared, and to increase the precision of effect estimates by 
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combining both direct with indirect evidence. 12, 13 This technique is already widely employed to compare the effectiveness of pharmacological interventions, 31 and is also being used for diagnostic test accuracy and surgical interventions evaluations. [32] [33] [34] [35] However, the assessment of non-pharmacological complex interventions through a network of comparisons is still unusual, [36] [37] [38] and few studies using this technique in the field of medication adherence have been published. [14] [15] [16] Complex interventions are usually described as those that contain several interacting components, being usually unclear which of the components provide the greater effect. Thus, the report and evaluation of these interventions may be challenging, also because their effectiveness and the replicability rely on how the intervention was designed (e.g. choice and total number of core components) and provided. 39, 40 This results in an excessive number of different interventions available, which may limit the ability to perform pairwise meta-analysis and increases the heterogeneity among trials. [41] [42] [43] In this case, the use of network meta-analysis proved to be a reliable and valuable method for the comparative assessment of complex interventions such as those design to improve patient's medication adherence. In this study, five robust networks involving a maximum of 91 studies and comparing 10 different complex interventions (including both single and multicomponent interventions) and standard care were built. Another parameter that is usually related to a considerable increase in the heterogeneity among studies, is the use of a range of different measures to assess medication adherence. 5 Subjective measurements such as self-report and healthcare professional assessments require the health care provider's or patient's evaluation of their medication-taking behavior. 44 The most common drawback in this case is that patients tend to underreport medication nonadherence to avoid disapproval from their healthcare providers. Nonetheless, the low cost, simplicity, and real-time feedback of these methods have contributed to their widespread use. 45, 46 Objective measures, including pill counts, electronic monitoring, secondary database analysis and biochemical measures, are thought to represent an improvement over subjective measures. 6, 47 A review of studies comparing MEMS with other methods reported that adherence was overestimated by 17% using self-report measures and by 8% using pill count. 11 However, other studies showed a moderate to high correlation of these measures, [48] [49] [50] [51] and some researchers also stated that multi-subjective-measure approach may have higher sensitivity over employing a single objective measure. 6, 50 Overall, small differences among adherence rates from subjective and objective measures were found, with similar patterns between the measures in the consistency analyses. Moreover, a deeper analysis of the primary studies reporting more than one measure, revealed that adherence rates were similar among different measures. [52] [53] [54] Thus, it is possible that multiple adherence methods can be used effectively to reflect the impact of a given intervention. However, for this to occur, measures and their assessment methods must be fully described and should include standardized operational definitions of medication adherence. This would facilitate comparisons between studies and settings. 55 The methodological and reporting quality of the studies included in this systematic review was moderate. As highlighted by the methodological quality assessment, some domains had unclear risk of bias, and due to incomplete outcome data, some studies were considered as having high risk of bias. An alternative solution to address the challenge of analyzing different measures for patients' adherence when data is heterogeneous may be a combination of measures. 50 Some authors have previously recommended the development of a composite measure for the establishment of a broader and more detailed picture of medication adherence. 5 In this systematic review with network meta-analysis, an overall composite measure (accounting for both objective and subjective measures) and an objective composite measure (accounting for pill count and MEMS measures) were created. The results obtained for these two composite measures were similar and reflected the results of each single measure. Moreover, the composite measures allowed the comparison of more interventions in one single model, which enabled other statistical differences to be obtained. Overall, for all the measures of adherence, results showed that some interventions (educational + technical; educational; technical) performed significantly better than standard care. The intervention economic + technical was the only one considered superior to all the other interventions and standard care. The score results also revealed compelling evidence that economic and technical components of interventions performed better than educational or attitudinal alone for improving patients' adherence in a short-term period of follow-up. Standard care was always ranked as the last option. These findings are at odds with those in some previous reports and meta-analyses that highlight the contribution of technical or financial components in complex interventions. 14, 15, 20, 56 However, this study differs to other reviews 3,57 that indicate no significant difference among interventions.
This could be partly explained by the broader analytical approach used in this study, the number of included trials, the design of a composite measure, the categorization of the adherence-enhancing interventions used, and the short follow-up period considered for analyses. It is known that medication non-adherence is affected by multiple determinants, including treatment duration, and the core components of the interventions. 1, 58 Further studies assessing their long-term effect on adherence rates should be conducted, using network meta-analysis to better define the profile of these complex interventions.
The findings of this study have methodological and clinical implications. The main strength of this work is the assessment of large networks of evidence for different measures of adherence, which allowed for a broad evaluation of the effectiveness of different complex interventions. The use of robust statistical methods to compare the effect of complex interventions on different outcomes in future studies is strongly recommended. The use of a composite measure seems reasonable to account for any adherence measure but should be further investigated in long-term analyses. Whenever possible, outcome measures and definition of complex interventions for adherence research should be standardized during the conduction and report of studies to improve their methodological quality, comparability, and consequently the formulation of recommendations.
This study has some limitations. To assist interpretability, the adherence-enhancing interventions were grouped into four main categories based on previous literature, but a different approach of categorization might alter some results. The existing evidence limited some of the analyses. Very few trials were available for some of the interventions assessed and not all the possible combinations of core components could be evaluated for all the measures of adherence. Only studies performing short-term assessments of patients' adherence were included in order to maintain a homogenous period of evaluation.
Other results may be obtained for different follow-up periods.
Conclusion
Using the network meta-analysis technique, it was possible to compare different measures of adherence for several complex interventions obtaining robust networks with consistent results. Different measures of adherence produced similar results, and the use of composite measures revealed as reliable alternatives to establish a broader and more detailed picture of medication adherence. The comparative effectiveness of the interventions' components should be investigated in long-term studies.
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